Boston Scientific (BSX) EBT Margin (2009 - 2026)
Boston Scientific (BSX) posted quarterly EBT Margin of 19.48% for Q2 2026, up 88.0% year-over-year from 10.36% in Q2 2025, and down 12.78% on a QoQ basis from 22.33% in Q1 2026.
Boston Scientific (BSX) EBT Margin (2009 - 2026) Analysis & Trends
Boston Scientific has reported EBT Margin for 18 years, with the latest figure at 19.48% in Q2 2026.
- EBT Margin for Q2 2026 came in at 19.48%, up 88.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 18.39% (up 217.0% YoY), and the FY2025 annual result was 16.86%, up 324.0% from the prior year.
- EBT Margin retreated to 19.48% in Q2 2026, from 22.33% in the prior quarter.
- Over five years, EBT Margin peaked at 22.33% in Q1 2026 and troughed at 5.16% in Q1 2022.
- A 5-year average of 14.2% and a median of 13.4% in 2023 frame the typical range for EBT Margin.
- The widest annual swing landed in 2022, when EBT Margin sank 874 bps; it then surged 957 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 12.21% in 2022, then gained by 11 bps to 13.56% in 2023, then decreased by 5 bps to 12.83% in 2024, then grew by 3 bps to 13.24% in 2025, then surged by 47 bps to 19.48% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 19.48% in Q2 2026, 22.33% in Q1 2026, and 13.24% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.32% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 11.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.48% |
| Mar 31, 2026 | 22.33% |
| Dec 31, 2025 | 13.24% |
| Sep 30, 2025 | 18.54% |
| Jun 30, 2025 | 18.59% |
| Mar 31, 2025 | 17.26% |
| Dec 31, 2024 | 12.83% |
| Sep 30, 2024 | 15.89% |
| Jun 30, 2024 | 10.19% |
| Mar 31, 2024 | 15.77% |
| Dec 31, 2023 | 13.56% |
| Sep 30, 2023 | 17.30% |
| Jun 30, 2023 | 11.84% |
| Mar 31, 2023 | 13.10% |
| Dec 31, 2022 | 12.21% |
| Sep 30, 2022 | 7.73% |
| Jun 30, 2022 | 10.64% |
| Mar 31, 2022 | 5.16% |
| Dec 31, 2021 | 3.81% |
| Sep 30, 2021 | 16.47% |